BioTech 365

OCTOBER 20, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson’s .Chase,

Trials 40

Trials Research 40

Pharma Times

AUGUST 11, 2023

Data supports further exploration of candidate as a rapid-acting anti-depressant for home use - News - PharmaTimes

102

102

Drug Discovery World

DECEMBER 22, 2023

News round-up for 18-22 December by DDW Digital Content Editor Diana Spencer. There have been some ground-breaking advances in women’s health this week, with new treatments for hot flushes and pregnancy sickness, and a discovery that could aid in development of treatments for secondary breast cancer.

Drugs 52

Drugs Antibody FDA Approval Clinical Trials 52

Drug Discovery World

NOVEMBER 3, 2023

News round-up for 30 October – 3 November by DDW Editor Reece Armstrong My news highlights this week feature a variety of exciting clinical trial results and launches that are examining therapies for much-needed disease areas, new drug approvals and even a space mission with a pharma twist.

Drugs 52

Drugs Gene Therapy Clinical Trials Clinical Trials 52

STAT News

MARCH 17, 2023

It was an abrupt end to what Nicholson depicted just months earlier as a booming business with plans for new clinics and treatments. To patients, the news came as a complete shock. Read the rest…

124

124

XTalks

SEPTEMBER 28, 2023

a Texas-based pharmaceutical firm specializing in psychotropic drug development, revealed that its groundbreaking antidepressant, Exxua (gepirone extended release) for treating major depressive disorder (MDD), received US Food and Drug Administration (FDA) approval on September 22, 2023. Fabre Kramer Pharmaceuticals, Inc.,

FDA Approval 105

FDA Approval Clinical Trials Clinical Trials Trials 105

Drug Discovery World

DECEMBER 27, 2023

There have been some ground-breaking advances in women’s health this week, with new treatments for hot flushes and pregnancy sickness, and a discovery that could aid in development of treatments for secondary breast cancer. You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

FDA Approval 52

FDA Approval Antibody Drugs Trials 52

Drug Discovery World

DECEMBER 5, 2022

DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry news. . The industry has seen breakthroughs announced in malaria treatment, epilepsy and major depressive disorders.

Drugs 52

Drugs Research Gene Therapy Gene 52

Drug Discovery World

DECEMBER 2, 2022

News round-up for 28 November – 2 December by DDW Digital Content Editor Diana Spencer . The last seven days have seen breakthroughs announced in malaria treatment, epilepsy and major depressive disorders. Injectable drug could offer new option for depressive disorders .

Drugs 52

Drugs Development Medicine Research 52

XTalks

AUGUST 9, 2023

Biogen and Sage’s Zurzuvae (zuranolone) has been approved by the US Food and Drug Administration (FDA) as the first oral medication for the treatment of postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy, according to the FDA.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials Trials 52

The Pharma Data

NOVEMBER 13, 2020

Outcomes Vary for Depression Collaborative Care Programs. 13, 2020 — Real-world collaborative care programs for depression show large variation in clinical outcomes, according to a study published in the November issue of Health Affairs. More News Resources. Professional. FRIDAY, Nov. Jürgen Unützer, M.D.,

Trials 52

Trials Research 52

Drug Discovery World

DECEMBER 27, 2023

There have been some ground-breaking advances in women’s health this week, with new treatments for hot flushes and pregnancy sickness, and a discovery that could aid in development of treatments for secondary breast cancer. You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

FDA Approval 52

FDA Approval Antibody Drugs Trials 52

Drug Discovery World

JANUARY 20, 2023

News round-up for 19-20 January by DDW Digital Content Editor Diana Spencer. Clinical trials have led our news section this week, with positive results announced from several Phase I and II studies.

Drugs 52

Drugs Clinical Trials Clinical Trials Trials 52

The Pharma Data

JANUARY 26, 2021

Anxiety, Depression Remain High Following Initial Lockdown. 26, 2021 — Depression and anxiety rates remain elevated following the initial COVID-19 lockdown, according to a study published online Jan. Depression was more likely among men, while anxiety was more likely among women. More News Resources. Professional.

Research 52

Research 52

The Pharma Data

JANUARY 7, 2021

Mindfulness-Based Cognitive Therapy Aids Depressive Disorder. 7, 2021 — Mindfulness-based cognitive therapy (MBCT) can impact how individuals with recurrent depressive disorder relate to themselves, according to a study published online Jan. More News Resources. Professional. THURSDAY, Jan. Elisabeth Schanche, Ph.D.,

Research 52

Research Development 52

The Pharma Data

NOVEMBER 16, 2020

Loneliness Tied to Depression in Adults Older Than 50 Years. 16, 2020 — Loneliness may be responsible for up to 18 percent of depression cases among people older than 50 years in England, according to a study published online Nov. increase in depressive symptom severity score averaged across all follow-ups. Professional.

Research 52

Research 52

Drug Discovery World

JUNE 29, 2023

To mark the occasion, this article summarises the most recent news about the ways drug discovery is improving wellbeing and mental health through innovative new treatments and therapies.

Drugs 52

Drugs Trials Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 4, 2020

Psilocybin Promising for Treating Major Depressive Disorder. 4, 2020 — Psilocybin in the context of supportive psychotherapy may be effective for treating major depressive disorder (MDD), according to a study published online Nov. More News Resources. Professional. WEDNESDAY, Nov. 4 in JAMA Psychiatry. Davis, Ph.D.,

Medicine 52

Medicine Research 52

The Pharma Data

DECEMBER 9, 2020

Children’s Depression Symptoms Up During U.K. 9, 2020 — Children’s depressive symptoms increased substantially during the U.K. lockdown, there was a significant increase in depression symptoms, as measured by the Revised Child Anxiety and Depression Scale (RCADS) short form. More News Resources.

Research 52

Research 52

The Pharma Data

DECEMBER 14, 2020

Depression Linked to Suicidal Ideation Among Physicians. 14, 2020 — Depression , but not physician burnout, is associated with suicidal ideation among physicians, while burnout is associated with increased self-reported medical errors, according to a study published online Dec. More News Resources. Professional.

Medicine 52

Medicine Research 52

Drug Discovery World

OCTOBER 6, 2023

News round-up for 2-6 October by DDW Digital Content Editor Diana Spencer. Partners collaborate to unlock the human proteome X-Chem and the Structural Genomics Consortium (SGC) have entered a collaboration aimed at creating new chemical tools to study human proteins.

Drugs 52

Drugs Gene Editing Genome Genomics 52

XTalks

AUGUST 31, 2022

In this episode, Ayesha discussed the FDA approval of Axsome Therapeutics’ rapid-acting oral treatment Auvelity for the treatment of major depressive disorder (MDD). The approval makes Auvelity the first and only rapid-acting oral medication for depression, and the first and only oral NMDA receptor antagonist approved for MDD.

Gene Therapy 52

Gene Therapy FDA Approval Life Science Gene 52

Drug Discovery World

NOVEMBER 4, 2022

News round-up for 31 October – 4 November by DDW Digital Content Editor Diana Spencer . In a week that saw magic mushrooms making the headlines in the UK, we also reported on exciting potential new therapies for geographic atrophy and malaria prevention. Study shows ‘magic mushrooms’ could treat depression .

Gene Therapy 52

Gene Therapy Drugs Antibody Gene 52

Drug Discovery World

DECEMBER 5, 2022

The industry has seen breakthroughs announced in malaria treatment, epilepsy and major depressive disorders. The NHS in England has fast tracked another cancer drug, and, in Covid-19 news, researchers have emphatically proven that prednisolone should not be prescribed for olfactory disorders.

Drugs 52

Drugs Research 52

The Pharma Data

NOVEMBER 19, 2020

COVID-19-Related Job Insecurity Tied to Anxiety, Depression. 19, 2020 — Job insecurity as a result of the COVID-19 pandemic is associated with self-reported anxiety and depression among U.S. More News Resources. Professional. THURSDAY, Nov. young adults, according to a study published online Nov. Ganson, Ph.D.,

Development 52

Development Research 52

The Pharma Data

DECEMBER 14, 2020

14, 2020 — Having depression during childhood or in the teen years appears to increase the odds of illness and early death later on, researchers say. The new long-term study included nearly 1.5 Of those, more than 37,000 were diagnosed with depression at least once between the ages of 5 and 19 years. MONDAY, Dec.

Research 52

Research 52

The Pharma Data

JANUARY 11, 2021

When lifetime history of depression and anxiety disorders was taken into account, 60 percent of the association between ADHD and attempted suicide was attenuated. More News Resources. Professional. One in Four Women With ADHD Attempts Suicide. MONDAY, Jan. 21 in the Archives of Suicide Research. Esme Fuller-Thomson, Ph.D.,

Research 52

Research 52

The Pharma Data

DECEMBER 3, 2020

percent of respondents reported clinically significant levels of depression, generalized anxiety, and posttraumatic stress disorder (PTSD), respectively. The likelihood of scoring at clinically significant levels of depression, generalized anxiety, and PTSD was increased 1.6- More News Resources. Professional. THURSDAY, Dec.

Research 52

Research 52

The Pharma Data

NOVEMBER 18, 2020

young adults report symptoms of depression, with more than one-third reporting thoughts of death or suicide, according to the results of a survey released by the COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States. percent reporting at least moderate depressive symptoms in October. WEDNESDAY, Nov.

Research 52

Research 52

The Pharma Data

DECEMBER 4, 2020

4, 2020 — Depression, anxiety and suicidal thoughts are more common in children and teens with epilepsy than previously known, and they should be screened for such problems, researchers report. None had been diagnosed with depression, anxiety or suicidal thoughts (suicidality). FRIDAY, Dec. ” © 2020 HealthDay.

Research 52

Research Clinical Research 52

The Pharma Data

OCTOBER 16, 2020

16, 2020 — Women who suffer severe morning sickness may have higher risk of depression during and after pregnancy, according to a new British study. Nearly half of the women with severe morning sickness had depression in the first trimester and nearly 30% had depression after delivery. FRIDAY, Oct.

52

52

The Pharma Data

JANUARY 11, 2021

11, 2021 — COVID-19 survivors frequently experience fatigue or muscle weakness, sleep difficulties, and anxiety or depression at six months after acute infection, according to a study published online Jan. Twenty-three percent of patients reported anxiety or depression. More News Resources. Professional. MONDAY, Jan.

Antibody 52

Antibody Research 52

The Pharma Data

DECEMBER 9, 2020

9, 2020 — Mindfulness, meditation and survivorship education can help young breast cancer survivors overcome depression and other problems, a new study indicates. The researchers developed two six-week group behavioral interventions to help reduce depression, stress, fatigue and sleep problems in younger breast cancer patients.

Research 52

Research Development 52

The Pharma Data

JANUARY 14, 2021

Staff were surveyed using an anonymized web-based survey that included standardized questionnaires for depression , anxiety symptoms, symptoms of posttraumatic stress disorder ( PTSD ), well-being, and alcohol use; the survey was completed by 709 participants (41 percent doctors, 49 percent nurses, 10 percent other health care staff).

Nurses 52

Nurses Doctors Doctor Medicine 52

The Pharma Data

JANUARY 4, 2021

4, 2021 — The COVID-19 pandemic is taking a toll on the emotional health of pregnant women whose exercise routines have been disrupted because of the coronavirus, new research shows. Those women had higher depression scores than their counterparts who were able to exercise as usual, the researchers found. MONDAY, Jan.4,

Research 52

Research 52

The Pharma Data

NOVEMBER 16, 2020

The researchers found that participants from both groups, but especially those in the survey group, experienced a worsening of their symptoms of OCD, anxiety, and depression. OCD aggravation correlated with worsening of anxiety, depressive symptoms, and the extent of avoidance behavior. More News Resources. Professional.

Doctors 52

Doctors Doctor Research 52

The Pharma Data

NOVEMBER 12, 2020

12, 2020 — Women who struggle with mental health problems will sometimes forgo the most effective forms of birth control because of concerns about worsening those issues, but a new study delivers a reassuring finding: The pill and other forms of hormonal birth control do not raise depression risk. THURSDAY, Nov.

Hormones 52

Hormones Doctors Doctor Drugs 52